Actionable news
0
All posts from Actionable news
Actionable news in AQXP: AQUINOX PHARMACEUTICALS Inc,

Aquinox Pharma's lead product candidate flunks mid-stage study in atopic dermatitis; shares down 16% premarket

A 54-subject Phase 2 clinical trial, called KINSHIP, assessing Aquinox Pharmaceuticals' (NASDAQ:AQXP) lead product candidate, AQX-1125, in mild-to-moderate atopic dermatitis failed to beat placebo based on the primary endpoint of the change from baseline in Target Lesion Symptom Score at week 12.

CEO David...


More